I think they were asking is that your research in terms of fundamental analysis. The "research" you've just provided as an example is just TA/charting.
You can't compare to LDX as you have consistently been doing. The fundamentals of where they were at post non-approval is completely different to BOT's fundamentals post non-approval.
Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-23
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.005(1.18%) |
Mkt cap ! $780.0M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 43.3¢ | 42.5¢ | $653.4K | 1.521M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 286800 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 841351 | 8 |
View Market Depth
| Last trade - 11.50am 12/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |